Colchicine NDC 59651-455

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-455Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0455Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-455-01	59651045501	100 TABLET in 1 BOTTLE (59651-455-01)Marketed from Mar 22, 2022
59651-455-30	59651045530	30 TABLET in 1 BOTTLE (59651-455-30)Marketed from Mar 22, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Colchicine
Generic name (nonproprietary): colchicine
Active ingredients: Colchicine — .6 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215444
Marketing start: Mar 22, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Alkaloids (Chemical structure)
Identifiers: Product ID 59651-455_eedd0f18-16dc-4404-bc85-507ec93049e9SPL ID eedd0f18-16dc-4404-bc85-507ec93049e9SPL set ID dd93a40f-92ab-47ac-9083-b8a7a0b18ad6RxCUI 197541UNII SML2Y3J35T
Pharmacologic class: Alkaloid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651045501 followed by a unit qualifier and the quantity

Package 59651-0455-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 22, 2025.

Indications (excerpt from the label)

Colchicine is an alkaloid indicated for: Familial Mediterranean fever (FMF) in adults and children 4 years or older ( 1.2 ). 1.2 Familial Mediterranean Fever (FMF) Colchicine tablets are indicated in adults and children four years or older for treatment of familial Mediterranean fever (FMF).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)